Company news
Bloomios Inc. (OTC:BLMS) news
Bloomios Inc. news releases on 6ix. Latest, Aug 30, 2023: Bloomios Reports Q2 2023 Financial Results
Press releases & updates
Bloomios Reports Q2 2023 Financial Results
August 29, 2023
Bloomios Appoints Kevin Henry as National Sales Director
June 8, 2023
Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million
May 31, 2023
Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer
March 26, 2023
Bloomios Engages Hybrid Financial
February 22, 2023
Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer
October 27, 2022
Upexi Announces Sale of Select CBD Assets for $23.5 Million
October 27, 2022
Bloomios To Present at The 2022 LD Micro Main Event October 25-27
October 19, 2022
Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients
August 4, 2022
Bloomios to Present at the 2022 LD Micro Invitational June 7-9
May 25, 2022
Bloomios Expands Production Capacity by 300%, Setting Stage for Strong Growth in 2022
May 18, 2022
Bloomios Reports 2021 Revenue at Record $8.5 Million, up from $1.3 Million in 2020
April 19, 2022
Bloomios Selected as Exclusive Manufacturer for DRYWORLD's New Athletic Performance CBD Product Line
March 31, 2022
DRYWORLD Struts into Multi-Billion Dollar CBD Market
March 31, 2022
OTC Markets Group Welcomes New OTCQB Companies – March 21
March 21, 2022
Bloomios Engages CMA to Lead New Investor and Public Relations Campaign
March 16, 2022
Bloomios Begins Trading on OTCQB Venture Market as BLMS, as Hemp-Derived Cannabinoid Product Sales Exceed $8 million
March 15, 2022